SKbiotek API Building Facility

Callaghan | RED (CRE) executed a Basis of Design Engineering Study (BOD) for a new large scale Active Pharmaceutical Ingredients (API) Manufacturing Plant at SK biotek’s existing manufacturing campus located in Watery Ln, Townparks, Swords, Co. Dublin, Ireland.

The proposed new P2 process building will be constructed within the existing P2/P5 building footprint, incorporating a 3-story steel frame and metal clad structure spanning over 1024 m2. It will serve as a dedicated space for chemical synthesis, API intermediate isolation, and finished API product manufacturing. The expansion aims to increase output for existing customer API products and explore new product lines. The development process involved collaboration between SK biotek stakeholders and Callaghan | RED designers, resulting in a Basis of Design (BOD) report that defined project requirements and emphasized cost control.

The report included assessments such as P&IDs, Hazop studies, and compliance with active ingredients containment, explosion prevention, and GMP guidelines. A comprehensive 3D model of the development was created, enabling identification of spatial constraints, equipment layouts, and coordination requirements. The BOD report confirmed technical feasibility, alignment with SK biotek engineering guidelines, and provided an overall project budget estimate within +/- 20% accuracy. Commercial information and technical IP remain confidential. The BOD report supports the SKB biotek stage gate process and sets the foundation for future detailed design engineering.